Beginning Jan. 20, 2023, Medi-Cal Rx prior authorization (PA) requirements will be reinstated for 39 additional drug classes. Requirements apply to new start medications in these drug classes for beneficiaries 22 years of age and older.
| Medi-Cal Rx Reinstatement – Phase II, Wave I Drug Classes | ||
| All Other Dermatologicals | Corticotropins | Other Antibiotics |
| Anabolics | Emollients Protectives | Other Hormones |
| Androgens | Erythromycins | Penicillins |
| Anesthetic Local Topical | Estrogens | Progesterone |
| Antiarthritics | Fat Soluble Vitamins | Streptomycins |
| Antifungals | Folic Acid Preparations | Sulfonamides |
| Antimalarials | General Antibacterials and Antiseptics | Systematic Contraceptives |
| Antiparasitics | Glucocorticoids | TB Preparations |
| Antiparkinson | Iodine Therapy | Tetracyclines |
| Anti-Ulcer Preps/Gastrointestinal Preps | Multivitamins | Thyroid Preps |
| Antivirals | Muscle Relaxants | Topical Nasal and Otic Preparations |
| Biologicals | Non-Opioid Analgesics | Urinary Antibacterials |
| Cephalosporins | Ophthalmic Preparations | Vitamin K |
For full details, please review the Dec. 20 notification from DHCS. You can also keep up to date on Medi-Cal reinstatement on the Medi-Cal Rx Education and Outreach webpage.
Additional resources
Important upcoming dates
- Feb. 24, 2023: PA requirements will be reinstated for all remaining Standard Therapeutic Classes (STCs) for beneficiaries 22 and older (Phase II, Wave 2).
- March 24, 2023: DHCS will begin to lift transition policies that were in place for beneficiaries ages 22 years and older (Phase III).
Questions?
Call the Medi-Cal Rx Customer Service Center at 800-977-2273 (available 24/7) days a week or email Medi-Cal Rx Education & Outreach at [email protected].
